iTonic Holdings Ltd Class A Ordinary Shares (ITOC)
Stock · NASDAQ · Health Care
$3.84as of 10/16/2026
Price chart
Active signals
ITOC Signal Track Record
How signals performed across all stocks →What ITOC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 11 | +0.3% | 55% | September 16, 2026 |
| Bollinger Band Breakdown | 8 | +2.8% | 63% | September 29, 2026 |
| Bollinger Band Breakout | 6 | -26.7% | 0% | October 6, 2026 |
| Any 20-session window (baseline) | -7.8% | 37% |
Computed by MarketWall from daily closing prices since June 24, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ITOC
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning sys…
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Employees
- 7
- Website
- www.ftzy.com.cn/ir/
Fundamentals
- 1-day range
- $4$4.22
- Market cap
- $4.94M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-0.32
- Dividend yield
- —
- Beta
- 0.35
- Avg. volume
- 51.1K
iTonic Holdings Ltd Class A Ordinary Shares Competitors
Chosen by industry and closest market cap.
- ITOCiTonic Holdings Ltd Class A Ordinary Shares$3.84▼ 4.24%Market cap $4.94MP/E —$3.51$18.4
- NUWENuwellis Inc. Common Stock$0.55▲ 0.00%Market cap $5.26MP/E 0.03$0.4444$172.9
- NDRAENDRA Life Sciences Inc. Common Stock$4.74▼ 7.06%Market cap $5.68MP/E —$2.96$8
- NXLNexalin Technology Inc. Common Stock$2.35▼ 4.08%Market cap $7.45MP/E —$2.38$50.7
- VBIOValion Bio Inc. Common Stock$1.17▼ 4.88%Market cap $1.14MP/E —$1.11$32.5
- IRIXIRIDEX Corporation Common Stock$0.81▼ 1.22%Market cap $14.61MP/E —$0.607$1.65
- QTIQT Imaging Holdings Inc. Common Stock$2.4▲ 0.84%Market cap $37.38MP/E —$2.38$19.05
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ITOC iTonic Holdings Ltd Class A Ordinary Shares | $4.94M | — | $3.84 | ▼ 4.24% | $3.51$18.4 |
| NUWE Nuwellis Inc. Common Stock | $5.26M | 0.03 | $0.55 | ▲ 0.00% | $0.4444$172.9 |
| NDRA ENDRA Life Sciences Inc. Common Stock | $5.68M | — | $4.74 | ▼ 7.06% | $2.96$8 |
| NXL Nexalin Technology Inc. Common Stock | $7.45M | — | $2.35 | ▼ 4.08% | $2.38$50.7 |
| VBIO Valion Bio Inc. Common Stock | $1.14M | — | $1.17 | ▼ 4.88% | $1.11$32.5 |
| IRIX IRIDEX Corporation Common Stock | $14.61M | — | $0.81 | ▼ 1.22% | $0.607$1.65 |
| QTI QT Imaging Holdings Inc. Common Stock | $37.38M | — | $2.4 | ▲ 0.84% | $2.38$19.05 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 9/21/2026
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga · 9/16/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
iTonic Holdings Announces 16-for-1 Share Consolidation
iTonic Holdings Ltd announced a 16‑for‑1 share consolidation that will take effect on October 6, 2026. The move will reduce the number of shares outstanding, which could affect liquidity and trading volume. The consolidation does not change the company’s market value or fundamentals. Investors should note the change when evaluating the stock’s price and trading dynamics.
iTonic Holdings Announces 16-for-1 Share Consolidation. iTonic Holdings Ltd announced a 16‑for‑1 share consolidation that will take effect on October 6, 2026. The move will reduce the number of shares outstanding, which could affect liquidity and trading volume. The consolidation does not change the company’s market value or fundamentals. Investors should note the change when evaluating the stock’s price and trading dynamics.